Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites

Abstract

Background Since the coronavirus disease 2019 (COVID-19) outbreak, many COVID-19 variants have emerged, causing several waves of pandemics and many infections. Long COVID-19, or long-term sequelae after recovery from COVID-19, has aroused worldwide concern because it reduces patient quality of life after rehabilitation. We aimed to characterize the functional differential profile of the oral and gut microbiomes and serum metabolites in patients with gastrointestinal symptoms associated with long COVID-19. Methods We prospectively collected oral, fecal, and serum samples from 983 antibiotic-naïve patients with mild COVID-19 and performed a 3-month follow-up postdischarge. Forty-five fecal and saliva samples, and 25 paired serum samples were collected from patients with gastrointestinal symptoms of long COVID-19 at follow-up and from healthy controls, respectively. Eight fecal and saliva samples were collected without gastrointestinal symptoms of long COVID-19 at follow-up. Shotgun metagenomic sequencing of fecal samples and 2bRAD-M sequencing of saliva samples were performed on these paired samples. Two published COVID-19 gut microbiota cohorts were analyzed for comparison. Paired serum samples were analyzed using widely targeted metabolomics. Results Mild COVID-19 patients without gastrointestinal symptoms of long COVID-19 showed little difference in the gut and oral microbiota during hospitalization and at follow-up from healthy controls. The baseline and 3-month samples collected from patients with gastrointestinal symptoms associated with long COVID-19 showed significant differences, and ectopic colonization of the oral cavity by gut microbes including 27 common differentially abundant genera in the Proteobacteria phylum, was observed at the 3-month timepoint. Some of these bacteria, including Neisseria, Lautropia, and Agrobacterium, were highly related to differentially expressed serum metabolites with potential toxicity, such as 4-chlorophenylacetic acid, 5-sulfoxymethylfurfural, and estradiol valerate. Conclusions Our study characterized the changes in and correlations between the oral and gut microbiomes and serum metabolites in patients with gastrointestinal symptoms associated with long COVID-19. Additionally, our findings reveal that ectopically colonized bacteria from the gut to the oral cavity could exist in long COVID-19 patients with gastrointestinal symptoms, with a strong correlation to some potential harmful metabolites in serum.

Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III

“…4‐chlorophenylacetic acid, a derivative of phenylacetate, is useful for the prevention or treatment of estrogen‐sensitive breast cancer 36,37 and human neuroblastoma 38 . 4‐chlorophenylacetic is correlated with intestinal flora 39 . Recent studies have shown that calcium intake and malnutrition can lead to outbreaks of SMA and changes in the gut microbiota are associated with its severity and progression 40 .…”

“… 38 4‐chlorophenylacetic is correlated with intestinal flora. 39 Recent studies have shown that calcium intake and malnutrition can lead to outbreaks of SMA and changes in the gut microbiota are associated with its severity and progression. 40 Our study showed that 4‐chlorophenylacetic acid was significantly and negatively associated with HFMSE and could be used as a marker for SMA classification.…”

Eliminating COVID‐19 as the immediate culprit for igniting pancreatitis

“…Intestinal barrier impairment, dysbiosis of gut microbiota, and perturbation of metabolites are prevalent occurrences among individuals with COVID‐19. Extensive research has consistently shown the association between microbiota composition and the morbidity, exacerbation, and mortality rates seen in COVID‐19 patients 51–55 . The gut microbiota facilitates the assessment of sickness severity in individuals with COVID‐19 56 .…”

“…patients. [51][52][53][54][55] The gut microbiota facilitates the assessment of sickness severity in individuals with COVID-19. 56 From a mechanical standpoint, it is observed that COVID-19 disrupts the composition of gut microbiota and metabolites.…”

The footprint of gut microbiota in gallbladder cancer: a mechanistic review

“…Viruses, especially Epstein-Barr virus (EBV) hidden in the human intestine, are also an important part of the gut microbiota that can promote the occurrence and development of GBC ( Xiong et al., 2023 ; Zhang et al., 2023 ). Although viruses are extremely minuscule, they are flexible and promote tumorigenesis through different pathways involving signal transduction changes, the DNA damage response and immune regulation ( Krump and You, 2018 ).…”